Ehrlichioses in humans: Epidemiology, clinical presentation, diagnosis, and treatment

Keyphrases

• Clinical Presentation 100%
• Ehrlichia 100%
• Clinical Treatment 100%
• Animal Epidemiology 100%
• Clinical Diagnosis 100%
• Human Ehrlichiosis 100%
• Human Granulocytic Anaplasmosis 66%
• Human Monocytic Ehrlichiosis 66%
• Opportunistic Infections 33%
• Anaplasma Phagocytophilum 33%
• Laboratory Methods 33%
• Tick-borne Diseases 33%
• Thrombocytopenia 33%
• Serological Test 33%
• Ehrlichia Chaffeensis 33%
• High Prevalence 33%
• Leukopenia 33%
• Case Fatality Rate 33%
• Polymerase Chain Reaction Assay 33%
• Serum Transaminase 33%
• Tick Vectors 33%
• Anaplasmataceae 33%
• Transaminase Activity 33%
• Laboratory Features 33%
• Clinical Similarity 33%
• Culture Test 33%
• Obligate Intracellular Bacteria 33%
• Ehrlichia Ewingii 33%
• Doxycycline Treatment 33%
• In(III) 33%
• Undifferentiated Fever 33%
• Blood Smear Examination 33%

Medicine and Dentistry

• Cohort Effect 100%
• Human Granulocytic Anaplasmosis 100%
• Ehrlichiosis 100%
• Infection 60%
• Prevalence 40%
• Human Monocytic Ehrlichiosis 40%
• Diseases 40%
• Opportunistic Infection 20%
• Anaplasma phagocytophilum 20%
• Case Fatality Rate 20%
• Thrombocytopenia 20%
• Tick Vector 20%
• Leukopenia 20%
• Blood Smear 20%
• Doxycycline 20%
• Ehrlichia Chaffeensis 20%
• Transaminase 20%
• Ehrlichia ewingii 20%
• Anaplasmataceae 20%
• Polymerase Chain Reaction 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Human Granulocytic Anaplasmosis 100%
• Ehrlichiosis 100%
• Infection 60%
• Prevalence 40%
• Human Monocytic Ehrlichiosis 40%
• Diseases 40%
• Intracellular Bacterium 20%
• Opportunistic Infection 20%
• Anaplasma phagocytophilum 20%
• Aminotransferase 20%
• Case Fatality Rate 20%
• Tick Vector 20%
• Ehrlichia Chaffeensis 20%
• Ehrlichia ewingii 20%
• Anaplasmataceae 20%
• Thrombocytopenia 20%
• Doxycycline 20%
• Leukopenia 20%